An amended in vitro-in vivo extrapolation model that accounts for first pass clearance effects on chemical bioaccumulation in fish

被引:0
|
作者
Saunders, Leslie J. [1 ]
Nichols, John W. [2 ]
Arnot, Jon A. [1 ,3 ]
Armitage, James M. [4 ]
Wania, Frank [1 ]
机构
[1] Univ Toronto Scarborough, Dept Phys & Environm Sci, Toronto, ON, Canada
[2] US Environm Protect Agcy, Duluth, MN USA
[3] ARC Arnot Res & Consulting, Toronto, ON, Canada
[4] AES Armitage Environm Sci Inc, Ottawa, ON, Canada
关键词
TROUT ONCORHYNCHUS-MYKISS; FRESHLY ISOLATED HEPATOCYTES; METABOLIC BIOTRANSFORMATION RATES; XENOBIOTIC INTRINSIC CLEARANCE; HYDROPHOBIC ORGANIC-CHEMICALS; BLOOD-FLOW; GASTROINTESTINAL-TRACT; BIOCONCENTRATION; BIOMAGNIFICATION; ELIMINATION;
D O I
10.1039/d2em00522k
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Measured rates of in vitro intrinsic clearance for fish may be extrapolated to the whole animal as a means of estimating a whole-body biotransformation rate constant (k(B); d(-1)). This estimate of k(B) can then be used as an input to existing bioaccumulation prediction models. Most in vitro-in vivo extrapolation/bioaccumulation (IVIVE/B) modeling efforts to date have focused on predicting the chemical bioconcentration in fish (aqueous only exposure), with less attention paid to dietary exposures. Following dietary uptake, biotransformation in the gut lumen, intestinal epithelia, and liver can reduce chemical accumulation; however, current IVIVE/B models do not consider these first pass clearance effects on dietary uptake. Here we present an amended IVIVE/B model that accounts for first pass clearance. The model is then used to examine how biotransformation in the liver and intestinal epithelia (alone or combined) may impact chemical accumulation that occurs during dietary exposure. First pass clearance by the liver can greatly reduce dietary uptake of contaminants, but these effects are only apparent at rapid rates of in vitro biotransformation (first order depletion rate constant k(DEP) >= 10 h(-1)). The impact of first pass clearance becomes more pronounced when biotransformation in the intestinal epithelia is included in the model. Modelled results suggest that biotransformation in the liver and intestinal epithelia cannot entirely explain reduced dietary uptake reported in several in vivo bioaccumulation tests. This unexplained reduction in dietary uptake is attributed to chemical degradation in the gut lumen. These findings underscore the need for research to directly investigate luminal biotransformation in fish.
引用
收藏
页码:741 / 754
页数:14
相关论文
共 50 条
  • [31] In vitro-in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization
    Morita, Keiichi
    Kato, Motohiro
    Kudo, Toshiyuki
    Ito, Kiyomi
    XENOBIOTICA, 2020, 50 (09) : 1064 - 1075
  • [32] In vitro-in vivo extrapolation of clearance: Modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods
    Poulin, Patrick
    Kenny, Jane R.
    Hop, Cornelis E. C. A.
    Haddad, Sami
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (02) : 838 - 851
  • [33] A Model Mechanism-Based Explanation of an In Vitro-In Vivo Disconnect for Improving Extrapolation and Translation
    Smith, Andrew K.
    Xu, Yanli
    Ropella, Glen E. P.
    Hunt, C. Anthony
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (01): : 127 - 138
  • [34] Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro-In Vivo Extrapolation Model
    Siccardi, M.
    Almond, L.
    Schipani, A.
    Csajka, C.
    Marzolini, C.
    Wyen, C.
    Brockmeyer, N. H.
    Boffito, M.
    Owen, A.
    Back, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (04) : 494 - 502
  • [35] Challenges and Opportunities for In Vitro-In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation
    Izat, Nihan
    Bolleddula, Jayaprakasam
    Abbasi, Armina
    Cheruzel, Lionel
    Jones, Robert S.
    Moss, Darren
    Ortega-Muro, Fatima
    Parmentier, Yannick
    Peterkin, Vincent C.
    Tian, Dan-Dan
    Venkatakrishnan, Karthik
    Zientek, Michael A.
    Barber, Jill
    Houston, J. Brian
    Galetin, Aleksandra
    Scotcher, Daniel
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (12) : 1591 - 1606
  • [37] Hepatic Scaling Factors for In Vitro-In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver Metastasis
    Vasilogianni, Areti-Maria
    Achour, Brahim
    Scotcher, Daniel
    Peters, Sheila Annie
    Al-Majdoub, Zubida M.
    Barber, Jill
    Rostami-Hodjegan, Amin
    DRUG METABOLISM AND DISPOSITION, 2021, 49 (07) : 563 - 571
  • [38] Using physiologically based pharmacokinetic modelling for in silico-in vitro-in vivo extrapolation to predict chemical exposure
    Lawless, M.
    Zhou, H.
    Fraczkiewicz, G.
    TOXICOLOGY LETTERS, 2016, 258 : S119 - S120
  • [39] Investigating the Theoretical Basis for In Vitro-In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways
    Benet, Leslie Z.
    Sodhi, Jasleen K.
    AAPS JOURNAL, 2020, 22 (05):
  • [40] Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CLp) from Hepatocyte Intrinsic Clearance (CLint)
    Manevski, Nenad
    Umehara, Kenichi
    Parrott, Neil
    MOLECULAR PHARMACEUTICS, 2023, 20 (07) : 3438 - 3459